PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of jexpmedHomeThe Rockefeller University PressThis articleEditorsContactInstructions for AuthorsThis issue
 
J Exp Med. 2009 November 23; 206(12): 2659–2669.
PMCID: PMC2806629

Molecular footprints of a germinal center derivation of human IgM+(IgD+)CD27+ B cells and the dynamics of memory B cell generation

Abstract

The origin of IgM+CD27+ B lymphocytes with mutated IgV genes, which account for ~20% of human peripheral blood (PB) B cells, is controversially discussed. A generation in a primary diversification pathway, in T cell–independent immune responses, or in T cell–dependent germinal center (GC) reactions has been proposed. We show here that IgM+IgD+CD27+ and IgM+IgD−/lowCD27+ B cell subsets carry, like class-switched memory B cells, mutations in the Bcl6 gene as a genetic trait of a GC experience. Moreover, the identification of PB IgM+IgD+CD27+ B cells clonally related to GC-derived IgG+ memory B cells with shared and distinct IgV gene mutations demonstrates the GC origin also of the former subset. These findings provide genetic evidence for a GC derivation of somatically mutated IgM+ B cells and indicate that adult humans harbor a large population of IgM+IgD+ post-GC memory B cells. Furthermore, the analysis revealed that a highly diverse and often very large population of memory B cells is generated from a given GC B cell clone, and that (preferentially IgM) memory B cells are generated already early in the GC reaction. This provides novel insights into the dynamics of GC reactions and the generation of a memory B cell repertoire.

Upon activation by T cell–dependent (TD) antigens, naive B cells are recruited into germinal centers (GCs; MacLennan et al., 1997). With appropriate stimulation by helper T cells and dendritic cells, the GC B cells clonally expand, diversify their Ig variable (IgV) region genes by somatic hypermutation (SHM), and are selected for increased affinity of their B cell receptor (BCR; Rajewsky, 1996). Independent from the process of SHM, class switching of the Ig heavy chain constant region from IgM to downstream Ig isotypes occurs in GC B cells (Shan et al., 1990; Harriman et al., 1993). Accordingly, somatically mutated IgV genes in combination with the expression of a class-switched BCR were considered as the hallmarks of the descendents of GC B cells, i.e., memory B cells and post-GC plasma cells (Hayakawa et al., 1987; Weiss and Rajewsky, 1990).

Approximately 10 yr ago, two IgM+ B cell subsets with mutated V genes were described in humans; they are a population of cells characterized by high expression of IgM but low IgD surface levels (IgM-only B cells) and IgM+IgD+CD27+ B cells (Klein et al., 1997, 1998; Tangye et al., 1998). Nearly all cells of these subsets carry somatically mutated IgV genes, but their mean mutation load is ~50–60% of that of class-switched memory B cells. As both mutated IgM+ B cell populations and the class-switched memory B cells share expression of the TNF-receptor superfamily member CD27, whereas unmutated naive B cells lack its expression, this marker was proposed to represent a general human memory B cell marker (Agematsu et al., 1997; Klein et al., 1998). The idea that the two IgM+ B cell subsets with mutated V genes are GC-derived memory B cells was supported by the observations that these cells are rare in newborn infants but accumulate with age (Agematsu et al., 1997; Zandvoort et al., 2001), are long-lived (Richards et al., 2000), show a propensity like class-switched memory B cells to differentiate into Ig-secreting cells upon appropriate stimulation (Agematsu et al., 1997; Bernasconi et al., 2002, 2003; Shi et al., 2003), and respond in vitro to various stimuli more similar to class-switched memory cells than to naive B cells (Tangye et al., 2003a, b; Good et al., 2006; Good and Tangye, 2007).

However, recent studies on human IgM+IgD+CD27+ B cells indicated that other mechanisms might be responsible for the generation and maintenance of these cells. Based on a reported dependency of these cells on the splenic environment, which is known to be important for T cell–independent (TI) type II immune responses, it was proposed that IgM+IgD+CD27+ (as well as IgM-only B cells, which were not distinguished in that work) are generated in TI responses (Kruetzmann et al., 2003). In another scenario, it was proposed that the mutated IgM+IgD+CD27+ B cells underwent SHM in a primary, antigen-independent diversification mechanism outside GC, as it is known to occur in sheep and rabbits (Weinstein et al., 1994; Reynaud et al., 1995). This idea was based on the observation that x-linked hyper-IgM patients apparently lack GC (caused by defective CD40L-signaling) and class-switched, as well as IgM-only, B cells, but still have substantial numbers of mutated IgM+IgD+CD27+ B cells (Weller et al., 2001, 2004). Several findings supported this scenario, including an analysis of CDRIII length diversity of the respective subsets, particularly the presence of rare mutated IgM+CD27+ B cells in fetal liver (Scheeren et al., 2008) and neonatal cord blood (Weller et al., 2001), as well as the detection of transcripts of activation-induced cytidine deaminase, an enzyme that is essential for SHM and class switching, in human cord blood transitional type 1/immature B cells (Kuraoka et al., 2009).

As IgM+IgD+CD27+ B cells and IgM-only B cells account for ~15 and 5% of human peripheral blood B cells, respectively, and occur at similar frequencies also in secondary lymphoid tissues (Pascual et al., 1994; Dunn-Walters et al., 1995), the cellular origin and functions of about a quarter of human mature B cells are currently controversially discussed.

To clarify whether mutated IgM+ B cells are post-GC cells, we analyzed molecular footprints of GC reactions in human B cell subsets. It has been shown that Bcl6, the master transcriptional regulator in GC B cells (Klein and Dalla-Favera, 2008), is affected by the SHM machinery in GC B cells, resulting in ~30% of GC and class-switched memory B cells carrying Bcl6 mutations in the intronic major mutation cluster (MMC; Pasqualucci et al., 1998; Shen et al., 1998; Peng et al., 1999). As SHM of IgV and non-Ig genes is strictly dependent on high-level transcription of the target sequences (Fukita et al., 1998; Bachl et al., 2001; Yang et al., 2006), Bcl6 should only be mutated in GC B cells that express high levels of this gene, but not in non-GC B cells that lack Bcl6 expression or show only low transcript levels. Thus, if the vast majority of IgM+CD27+ B cells acquired somatic IgV gene mutations in a GC-independent way, and hence in the absence of Bcl6 transcription, these cells should lack Bcl6 mutations. Second, if IgM+IgD+CD27+ and class-switched B cells derive from common GC B cell clones, one may find clonally related IgM+IgD+CD27+ and class-switched B cells in the PB, and these cells should carry shared and distinct somatic V gene mutations.

RESULTS

Bcl6 mutations in human CD27+ B cell subsets

We analyzed the mutation status of the Bcl6-MMC in FACS-sorted B cells from three healthy adult blood donors by single-cell PCR. This approach allows the reliable detection of rare mutations, as PCR-introduced mutations are negligible in the direct sequence analysis of the amplificates from single cells. As it is relevant for the determination of the mutation frequency whether one or both alleles of a cell were amplified, we analyzed donors who were prescreened to carry a known single-nucleotide polymorphism (SNP; rs3832246, 1 bp deletion) on one allele of Bcl6, so that for unmutated sequences it could also be determined whether one or both alleles were amplified. Overall, from ~21% of the cells (range 14–25%) both alleles were amplified (Table I). The Bcl6-MMC of all 60 PCR-positive naive B cells was unmutated, whereas 16 of 75 (21%) IgM+IgD+CD27+ B cells, 13 of 64 (20%) IgM-only, and 19 of 57 (33%) class-switched B cells carried mutations. In the CD27+ B cell subpopulations, 8–12 cells had a single mutation and 4–9 cells harbored 2–6 mutations per sequence. The mean mutation frequencies were 0.045% (range 0.036–0.084%) for IgM+IgD+CD27+ B cells, 0.050% (range 0.013–0.119%) for IgM-only B cells, and 0.085% (range 0.082–0.093%) for class-switched B cells. Thus, IgM+IgD+CD27+ and IgM-only B cells carry class-switched B cells in a fraction of cells Bcl6 mutations as a footprint of a GC passage of these B cells. The mutations were distributed throughout the whole MMC, and besides two 1-bp deletions and one 5-bp deletion, the mutations were single basepair substitutions with a bias for transitions in IgM+IgD+CD27+, IgM-only, and class-switched B cells (63, 58, and 46%, respectively, as compared with an expected frequency of 33% for unbiased mutations). The overrepresentation of transitions over transversions was statistically significant only for both IgM+ B cell subsets (P < 0.001 each), but not in those of class-switched B cells (P < 0.09). The RGYW and WRCY motifs are known SHM hotspots (Rogozin and Kolchanov, 1992), and each of the three CD27+ B cell subsets had an enrichment of mutations in RGYW/WRCY motifs. 28.6% of the mutations in IgM+IgD+CD27+, 18.5% in IgM-only, and 40.5% in class-switched B cells were within the motifs, in comparison to an expected frequency of 16.7%, assuming unbiased targeting of these motifs. The difference between observed and randomly expected targeting of RGYW/WRCY motifs reached statistical significance only for class-switched B cells (P < 0.001). However, in another study Bcl6 mutations in class-switched B cells from human tonsil also did not show significant RGYW targeting (Yavuz et al., 2002). The fact that the intrinsic SHM biases analyzed did not reach statistical significance in all instances might be caused by the restricted number of mutation events analyzed and/or by the fact that some Bcl6 mutations influence Bcl6 expression (Pasqualucci et al., 2003) and hence may be selected for or against.

Table I.
Bcl6 mutations in human PB B cells

Clonal relation of human IgM+IgD+CD27+ and class-switched memory B cells

If IgM+ memory B cells and class-switched B cells both are descendants of common GC B cell clones, it should principally be possible to find clonally related IgM+ and IgG+ B cells with shared and unique mutations in PB. We focused on IgM+IgD+CD27+ B cells because their origin is more controversial than that of IgM-only B cells (Weller et al., 2001), and for our analysis it would have been difficult to obtain enough cells from the small IgM-only subset.

Our first approach to identify such clonally related cells was based on a PAGE strategy and aimed at very large clones. Considering the number of cells that could be used per PCR reaction (30,000) and the total number of IgG+CD27+ and IgM+IgD+CD27+ B cells in the PB (~6 × 108 per subset), we calculated that a putative clone should have at least 20,000 members in each of the two subsets to be detectable by this approach. Several aliquots of 30,000 IgG+CD27+ and IgM+IgD+CD27+ B cells each were sorted from PB of 10 healthy donors. Extracted RNA was separately reverse transcribed with gene-specific primers for Cγ and Cμ/Cδ and amplified with a VH1 family-specific primer and the same Cγ and Cμ/Cδ primers (Fig. 1 A). The Cγ primer used in this and the experiment described further below is specific for the Cγ1 and Cγ3 genes, which are classically used by post-GC memory B cells, but does not amplify Cγ2 transcripts, which mainly derive from TI responses (Shackelford et al., 1988). All CH primers were complementary to positions in equal distance from the first coding nucleotide of the corresponding CH gene. Thus, an identical CDRIII length of putative clone members in IgM+IgD+CD27+ and IgG+CD27+ B cells would result in equal-size products in a CDRIII-spectratyping analysis, performed on neighboring lanes of a PAGE gel. Such bands of interest were cut out from the gel, reamplified, and sequenced. Overall, 120 pairs of identical length were analyzed from sorted cells of the 10 donors. Most of these products (85%) were oligo- to polyclonal and not further followed up. From the monoclonal products in one instance, clonally related VH1-18–expressing IgM and IgG transcripts were obtained, and after cloning of the amplificates 7 distinct IgG+ and 2 distinct IgM+ members of the clone were identified (Fig. 2 A). The clone members contained between 3 and 9 VH gene mutations per sequence, of which 1 to 7 were shared by at least two clone members. Importantly, the genealogical tree depicting the most likely clonal evolution revealed that several IgG+ clone members descended from a proposed intermediate with only a single point mutation, whereas the two IgM sequences shared 5 additional point mutations with the other IgG+ sequences. We conclude that the IgM+ B cells acquired most if not all of their mutations in the clonal evolution of the GC B cell clone that gave rise to these memory B cells.

Figure 1.
Flow charts of the experimental approaches used to identify clonally related sequences in PB IgM+ and IgG+ B cells. (A) PAGE–based approach. (B) CDRIII-specific primer−based approach.
Figure 2.
Genealogic trees of VH1-18–, VH6-, or VH3-23–expressing memory B cell clones, reconstructed from clonally related IgM+ and IgG+ sequences. Abbreviations in the circles represent single sequences from IgM+ (M) or IgG+ (G) B cells, empty ...

As the gel-based approach was restricted by the relatively small number of cells that could be analyzed for a clonal relationship, we established an RT-PCR–based approach with clone-specific primers to screen larger cell samples (Fig. 1 B). RNA from 106 to 1.5 × 106 sorted IgG+ and IgM+IgD+CD27+ B cells isolated from 8 adult peripheral blood donors, and in two instances from naive B cells (donors 7 and 8), was extracted and reverse transcribed with Cγ and Cμ/Cδ primers, respectively. The cDNAs from both subsets were amplified with primers for VH6-FR1 (donors 1–6) or VH3-23 leader peptide sequence (donors 7 and 8) in combination with nested constant region primers. The nesting effect of the second constant primer set prevents the amplification of VHDHJH-rearrangements from potential cell sorting contaminations, i.e., IgM transcripts from an IgG+ B cell sort and vice versa. By analyzing the single member VH6 family, we aimed to enhance the chance to find clonally related cells caused by a reduced heterogeneity of the population. However, as VH3-23 is one of the most frequently used VH gene segments (Brezinschek et al., 1995), we aimed to clarify whether clonally related IgM+IgD+ and IgG+ B cells can also be found for such a gene segment. The amplified VH6 and VH3-23 rearrangements of IgG+ B cells were cloned and a number of sequences (8 to 30 per PB donor) were randomly chosen to design CDRIII-specific primers. These primers were mainly binding to the 3′ end of CDRIII (and in several instances parts of FRIV), so that enough sequence from the 5′ part of CDRIII was included in the resulting amplificates to allow an unequivocal determination of the clonal relationship of the amplified rearrangements. The CDRIII primers were used together with the VH6 or VH3-23 primer to amplify clonally related sequences from the VH6-Cμ/Cδ– or VH3-23-Cμ/Cδ–amplified cDNA from IgM+IgD+CD27+ B cells, respectively.

From donors 1–6, we were able to amplify and directly sequence 21 monoclonal PCR products from VH6-expressing IgM+IgD+CD27+ B cells (range 2–5 per donor; oligo- or polyclonal amplificates caused by cross-hybridization of the “clone-specific” primers on other VH6 gene rearrangements were not further considered). Of these 21 products, 11 VH6 rearrangements from IgM+IgD+CD27+ B cells were clonally related to the respective VH6 rearrangements from the IgG+ B cells (Table II). From donors 7 and 8, we obtained 9 and 7 monoclonal PCR products, respectively, from VH3-23–expressing IgM+IgD+CD27+ B cells. Of these 16 products, 3 VH3-23 rearrangements from IgM+IgD+CD27+ B cells were clonally related to the respective VH3-23 rearrangements from the IgG+ B cells (Table II). With the “clone-specific” primers for these three memory B cell clones, no clonally related sequences were obtained from the corresponding naive B cells, although 14–21 sequences from the cloned PCR amplificates were analyzed for the three clones. Instead, the sequences from the naive B cells consisted of 4–10 different unmutated sequences with varying CDRIII length and composition (Fig. S1). As one would not expect to find naive B cell clone members among the isolated cells, the lack of CDRIII sequences shared by the naive and IgG+ B cells validates the reliability of the approach to identify clonally related sequences among the mutated IgD+IgM+ and IgG+ B cells.

Table II.
Clones with IgM+ and IgG+ members in human PB memory B cells

To study the intraclonal diversity of the clonally related VH-Cμ and VH-Cγ amplificates, for each of the 11 VH6 and 3 VH3-23 clones, PCR products obtained with the CDRIII-specific primers from the IgG+ and IgM+IgD+CD27+ B cells were cloned into plasmids and several of these were sequenced. Sequence alignments of five selected sequences per clone, including the initial IgG sequence, are depicted in Fig. S2.

For all 14 clones expressing VH6 or VH3-23, multiple distinct members, differing from each other by single, few, or >24 point mutations were found (Fig. 2). The overall mutation frequency of the IgG+CD27+ B cells (including clone A from the PAGE analysis) is 6.2% and of the IgM+IgD+CD27+ B cells 4.2%. Genealogical trees were generated to visualize the mutational evolution of the clones, and a heterogenous picture was obtained (Fig. 2). Moreover, in 6 clones, IgM members are mainly early progeny of the clones and hence carry relatively few mutations (Fig. 2, clones H-M), whereas the IgG+ post-GC B cells – with few exceptions – have acquired more shared and distinct mutations. In the other 9 clones, including clone A (Fig. 2, A–G, N, and O), IgG+ and IgM+ clone members are found more intermingled. Notably, also in these trees, IgG sequences on average carry more mutations than IgM sequences. Unmutated IgM+ sequences were detected in two clones (Fig. 2, E and L), and unmutated IgM and IgG sequences were detected in one clone (Fig. 2 G).

Considering the overall shapes of the trees depicting the clonal evolution of the B cell clones, a striking diversity is evident. Each clone consists of a high number of branches, and many distinct sequences were found. This shows that throughout the GC reaction, and starting early during clonal expansion and mutation accumulation, clone members are selected to leave the GC and become members of the memory B cell pool.

Assuming that all clone members in a sample were detected (certainly an underestimation), we estimated the total number of clone members in the PB of the donors. Counting repeatedly identified sequences only once, we calculated a clone size of 190 B cells for the smallest clone (Fig. 2) and 3,600 B cells for the largest clone (Fig. 2 M) detected in our study (see Materials and methods).

DISCUSSION

Human IgM-only and IgM+IgD+CD27+ B cell subsets carry molecular footprints of a GC reaction

To clarify the still unresolved origin of somatically mutated IgM+ B cells in humans, we analyzed mutations in the Bcl6 gene as a genetic trait of a previous GC experience. These mutations are found in ~30% of GC B cells and class-switched memory B cells and show key features of SHM (Pasqualucci et al., 1998; Shen et al., 1998). As the mutation frequency in Bcl6 is ~50–100-fold lower than the one of IgV genes (Pasqualucci et al., 1998), this explains why such mutations are not found in all class-switched memory B cells. Importantly, SHM is strictly dependent on transcription of its target genes (Fukita et al., 1998; Bachl et al., 2001; Yang et al., 2006). On this basis, we reasoned that Bcl6 mutations should only be present in IgM+ B cells with mutated IgV genes when these cells acquire their mutations in a GC reaction, i.e., when Bcl6 is strongly transcribed (Klein and Dalla-Favera, 2008). Indeed, although there is a low basal level of Bcl6 transcription in mature resting naive human B cells (Ye et al., 1993), this is further reduced when the cells undergo TI immune responses outside GC (Allman et al., 1996; Toellner, K.-M., personal communication). Thus, Bcl6 should not acquire mutations in case SHM would be active in TI responses. We cannot formally exclude that Bcl-6 is transcribed during the proposed primary V gene diversification pathway for the generation of somatically mutated IgM+IgD+CD27+ B cells; however, this seems very unlikely considering that Bcl6 is the master regulator of the GC B cell differentiation program (Klein and Dalla-Favera, 2008).

As somatic mutations in IgV genes and Bcl6 are generated by the same SHM machinery (Pasqualucci et al., 1998), one would expect that their levels are correlated, and this is exactly what we observed. Both IgM+CD27+ B cell subsets have ~50–60% of the mutation load of class-switched memory B cells in their IgV genes and in Bcl6. In conclusion, the detection of Bcl6 mutations in IgM+IgD+CD27+ and IgM-only B cells strongly argues that most if not all of these cells derive from a GC reaction.

Derivation of IgM+IgD+CD27+ and IgG+CD27+ B cells from common GC B cell clones

If one assumes that IgM+IgD+CD27+ and IgG+CD27+ B cells derive from common GC B cell clones, and hence both represent post-GC memory B cells, finding of clonally related IgM+ and IgG+ PB B cells would represent an important validation for this assumption. However, a clonal relationship as such does not discriminate between the three proposed origins of somatically mutated IgM+IgD+CD27+ B cells. If these cells acquire IgV gene mutations during an antigen-independent primary diversification process, these cells may also enter GC reactions upon TD activation and give rise to IgG+ memory B cells. Even if IgM+IgD+CD27+ B cells represent GC independent memory B cells from TI immune responses, such cells may, in particular circumstances, be driven into GC reactions and become IgG+ memory B cells. It is only the mutation pattern within a clone that can discriminate between the different scenarios. Several of the clones are indeed unhelpful in clarifying this issue. In three clones shown in Fig. 2 (I, K, and L), all IgG+ clone members may potentially derive from one prediversified IgM+ B cell or a memory B cell from a TI response that was driven into a GC reaction. However, in two other clones (Fig. 2 H) such a scenario is already less likely, as here one would have to postulate that two different members of a prediversified clone were driven into GC reactions. Importantly, the pattern of mutation accumulation in the other 10 clones (Fig. 2, A–G and M–O) is incompatible with a non-GC dependent scenario. In these clones, IgG and IgM members are intermingled in the genealogical trees, and some of the IgG cells can be found at earlier branches in the trees than IgM members, despite a number of shared mutations. Thus, in these clones IgG+ and IgM+ members coevolved from a common GC B cell clone.

The selective search for clonally related IgG+CD27+ and IgM+IgD+CD27+ B cells does not allow one to determine whether all or only a small fraction of IgM+IgD+CD27+ B cells were generated in GC reactions. Nevertheless, the fact that we found clonally related IgM+IgD+CD27+ B cells for ~40% of the informative IgG+ memory B cells (in total, 14 of 37 Cγ transcript sequences tested with monoclonal Cμ or Cδ amplificates) indicates that GC B cell clones regularly give rise to both IgM and IgG memory B cells. That we did not find IgM+ members for all clones may simply be caused by technical matters (e.g., mutations in IgM+ clone members at primer binding sites) or a smaller size of many memory B cell clones, so that in the aliquot of PB that we analyzed no IgM members were present (note that we sampled ~10% of PB B cells, but as only 2% of lymphocytes are present in PB [Blum and Pabst, 2007], overall we analyzed only an aliquot of 0.2% of B cells). Moreover, it is remarkable that in many of the clones the number of (distinct) members was similar for IgM+ and IgG+ B cells, which indicates that for at least half of the IgG+ memory B cells a population of clonally related IgM+ memory B cells of similar size exists. Considering that the frequency of IgG+ memory B cells in the PB is similar to the frequency of IgM+CD27+ B cells, this, together with the results of the Bcl6 mutation analysis, suggests that indeed most if not all of the IgM+CD27+ B cells in human adults are post-GC B cells.

How do these findings relate to the indications for a generation of somatic mutations in IgM+IgD+CD27+ (and IgM-only) B cells by a prediversification mechanism or in the course of TI immune responses? Regarding an origin of IgM memory B cells from TI responses, it may well be that a small fraction of these cells were indeed generated in such immune reactions. However, the reported specific dependence of IgM memory B cells from the spleen with its marginal zone, and hence the association with TI type II responses (Kruetzmann et al., 2003), was not seen in several other studies (Weller et al., 2004; Wasserstrom et al., 2008; Martinez-Gamboa et al., 2009), and there is evidence from studies in rodents that the marginal zone is also a reservoir for post-GC memory B cells (Liu et al., 1988; Song and Cerny, 2003), so a relationship between PB IgM+CD27+ B cells and splenic marginal zone B cells does not argue against a GC derivation of the cells. Regarding the evidence for a prediversification mechanism in IgM+IgD+CD27+ B cells, the recent description of a small population (3–5% of IgD+ B cells) of somatically mutated IgM+IgD+CD27+ B cells in fetal tissues indeed argues for a GC-independent development of these cells (Scheeren et al., 2008). Importantly, however, only ~20% of these fetal IgM+CD27+ B cells harbor somatic mutations, and the mutation load in these mutated cells was only about half of that of IgM+IgD+CD27+ B cells in adults (Klein et al., 1998). Another main argument for a GC-independent origin of mutated IgM+IgD+CD27+ B cells relates to their presence in children affected by the x-linked hyper IgM syndrome (Weller et al., 2001). However, in these patients only a fraction of IgM+IgD+CD27+ B cells carried mutated V genes, and a recent study indicated that the mutation frequency of the mutated V genes is often considerably lower than that of the corresponding B cells from healthy individuals (Longo et al., 2009). Moreover, in x-linked hyper IgM patients, there could be an unphysiological expansion of the prediversified IgM+IgD+CD27+ B cells in the absence of competition with a normal population of memory B cells for survival niches. Finally, it may also be that GC-like structures exist in such patients and that memory B cells generated in such structures preferentially give rise to IgM+IgD+CD27+ B cells in the absence of CD40-triggering for class-switching. Taking these considerations together, a picture is emerging in which some IgM+IgD+CD27+ B cells are initially generated during early development in a primary antigen-independent diversification process, with a relatively low mutation load. Later in life, the majority of cells with this phenotype appear to derive from GC reactions and hence represent post-GC memory B cells.

Dynamics of memory B cell generation in the GC

The detection and characterization of rearranged IgV genes from memory B cell clones not only showed that IgG+ and IgM+IgD+CD27+ memory B cells can derive from the same GC B cell clone, but provided additional insights into the dynamics of memory B cell generation in the human. First, GC B cell clones give rise to memory B cells throughout the GC reaction, and begin to do so very early in the response, as evident from PB memory B cells with very few or even a lack of IgV gene mutations. This finding provides evidence that lowly mutated memory B cells are not derived from particular immune reactions associated with diminished V gene diversification and/or hampered T cell help. Moreover, the detection of unmutated members of memory B cell clones might indicate that the few unmutated B cells that were described in previous V gene studies of CD27+ B cells are (mostly) memory B cells and not cell sorting contaminants. Also class switching is initiated very early during the clonal expansion, as multiple IgG+ clone members with few somatic mutations were detected. Second, the population of memory B cells generated from a GC B cell clone is often very diverse in terms of V gene sequences. This implies that memory B cells with a wide spectrum of affinities and antigen-binding characteristics is generated from a GC B cell clone. This might facilitate the recognition of slightly modified pathogens in recall responses by the memory B cell pool. Third, although IgM and IgG cells are often found intermingled in the genealogical trees, there is a clear tendency that IgM+ memory B cells were generally generated earlier than IgG+ memory B cells and hence show a lower overall mutation load (4.2% for IgM+ cells versus 6.2% for IgG+ memory B cells). These values are the same as those determined previously for the populations of IgM+IgD+CD27+ and IgG+ memory B cells (Klein et al., 1998). Therefore, our analysis of clonally related IgM+IgD+CD27+ and IgG+ memory B cells indicates that a main determinant for the lower mutation load of the mutated IgM+ B cells is their earlier generation during GC reactions, and not, for example, a generation in separate, perhaps less efficient GC responses.

Concluding remarks

The results of the present study indicate that there is a large population of IgM+ memory B cells in human adults. Although the lower mutation load of these cells as compared with class-switched memory B cells may imply that the antibodies produced by these cells are usually of lower affinity that the one of IgG antibodies, this may be compensated for by the higher avidity of the pentameric IgM complexes when B cells differentiate into plasma cells and secrete antibody. Moreover, these memory B cells may serve as a flexible memory B cell reservoir that may reenter GC upon encounter with the same or a similar antigen to undergo further affinity maturation and be able to switch the isotype of their BCR to the needs of the particular recall response.

Besides the importance of revealing the origin of about a quarter of the human B cell pool, the present work also has important implications regarding the origin and consequence of dysregulated B cells in autoimmune diseases and immunodeficiencies, as well as B lymphoid malignancies. For example, many mature B cell lymphomas with somatically mutated IgV genes express IgM (and often also IgD), and the present study therefore supports the view that these are GC B cell–derived lymphomas (Küppers et al., 1999).

MATERIALS AND METHODS

Cell separation.

Buffy coats of healthy adult donors were obtained from the blood bank of the Institut für Transfusionsmedizin of the Medical School of the University of Duisburg-Essen. Donors for full blood donations were recruited from the Medical School. All samples were collected with informed consent of the donors. The study protocol was approved by the Internal Review Board in Essen. PB mononuclear cells were isolated by Ficoll-Paque density centrifugation, and CD19+ B cells were enriched to >98% by magnetic cell separation using the MACS system (Miltenyi Biotec).

Cell sorting.

The B cell–enriched cell suspensions were stained with CD27-APC (eBioscience), anti–human IgD-PE, and IgM-FITC or IgG-FITC antibodies (all from BD). B cell subpopulations were sorted with a FACSDiva cell sorter (BD) as naive B cells (IgM+IgD+CD27), class-switched memory B cells (IgG+CD27+), IgM+IgD+CD27+ B cells (IgM+IgD+CD27+), and IgM-only B cells (IgM+IgD−/lowCD27+). Purity was >99% for each population as calculated by reanalysis on a FACSCanto flow cytometer (BD) in combination with FACSDiva software.

Bcl6 mutation analysis.

Single cells were sorted into Expand High Fidelity PCR buffer (Roche) and incubated with 0.25 mg/ml proteinase K for 2 h. A semi-nested PCR strategy was used to amplify the Bcl6-MMC with a length of 744 bp (Pasqualucci et al., 1998). The first round of amplification was performed in 2.5 mM MgCl2, 125 µM dNTPs, 0.125 µM each primer (5′-CGCTCTTGCCAAATGCTTTGGC-3′ and 5′-CTCTCGTTAGGAAGATCACGGC-3′), and 1.2 U High Fidelity DNA polymerase mix (Roche). For the second round of amplification, 1.5 µl of the first round reaction were used as template. PCR conditions were 1.75 mM MgCl2, 67 µM dNTPs, 0.125 µM each primer (5′-CGCTCTTGCCAAATGCTTTG-3′ and 5′-GACACGATACTTCATCTCATC-3′), and 1.2 U Fermentas Taq DNA polymerase. For sequence analysis, PCR products were purified with EZNA Cycle pure kit (VWR International GmbH) and sequenced from both strands with second round amplification primers. The procedure was accomplished using the ABI Cycle Sequencing Kit, version 3.1 on an ABI3130 Sequencer (Applied Biosystems). Sequence analysis was performed using the SeqScape software version 2.5 (Applied Biosystems) and the GenBank data library. To calculate whether one or two alleles were amplified from a cell, donors were prescreened for heterozygosity of a known monoallelic SNP in the Bcl6-MMC, a 1-bp deletion (rs3832246).

Clonal relation in PB B cells: PAGE strategy.

IgG+CD27+ B cells and IgM+IgD+CD27+ B cells were sorted (as described in the Cell sorting section) in 30,000 cell aliquots. RNA was extracted with RNeasy micro kit (QIAGEN) and RT was performed with Superscript-III-RT (Invitrogen) according to the manufacturer’s protocol. For gene-specific RT of RNA from class-switched B cells, a primer was used that recognizes Cγ1 and Cγ3 (5′-AGGCAGCCCAGGGCCGCTGTGCC-3′), and for RNA from IgM+IgD+CD27+ B cells a mixture of a Cμ (5′-AGCCAACGGCCACGCTGCTCGTAT-3′) and a Cδ primer (5′-CATGCCAGGACCACAGGGCTGTTATC-3′) was used. The distance to the 3′ end of the rearranged JH gene is identical for the three primers. VH1 family-specific cDNA was amplified in 1.5 mM MgCl2, 250 µM dNTPs, 0.125 µM each primer (VH1FR2 5′-GGTGCGACAGGCCCCTGGACAA-3′ and constant primers as in RT), and 1.2 U High Fidelity DNA polymerase mix (Roche) in 35 cycles. PCR products were precipitated, resolved in 10 µl formamide and heat-denatured at 95°C for 2 min. Samples were loaded in neighboring lanes of a 6% denaturing PAGE gel (19:1 acrylamide/bisacrylamide, 7 M urea in TBE buffer). The gel was stained with the Silver sequence DNA staining kit (Promega) according to the manufacturer’s instructions. PCR products of equal size in both lanes were excised and watered O/N in 50 µl H2O. 5 µl were reamplified in additional 35 PCR cycles and sequenced with the VH1FR2 primer. Products with identical, monoclonal CDRIII in both populations were cloned using pGEM-T-Easy cloning kit (Promega) and sequenced to identify clone members (Fig. 1 A).

Clonal relation in PB B cells: CDRIII-primer strategy.

From 1 to 1.5 × 106 cell aliquots of IgG+CD27+ B cells and IgM+IgD+CD27+ B cells from donors 1–8 and of naive B cells from donors 7 and 8, cDNA was prepared as described in the previous section and amplified in 1.5 mM MgCl2, 250 µM dNTPs, 0.125 µM each primer (VH6FR1 5′-GGTGCGACAGGCCCCTGGACAA-3′ or VH3-23-leader peptide sequence 5′-TTTGGGCTGAGCTGGCTTTTTCTTGTG-3′ and either a Cγ RT-primer or nested primers for Cμ 5′-TCGTATCCGACGGGGAATTCTCACAG-3′ and Cδ 5′-GTTATCCTTTGGGTGTCTGCACCCTG-3′), and 1.2 U High Fidelity DNA polymerase mix (Roche) for 35 cycles. The cDNA of IgG+ B cells was cloned using the pGEM-T-Easy cloning kit (Promega), and multiple plasmids per cloning were sequenced. For 8–30 sequences of each donor, CDRIII-specific primers were generated. PCR conditions were determined that were suitable to amplify for most of the clone-specific primers products from the corresponding diluted plasmid preparations (5 ng/µl) in no more than 35 cycles. PCR for the detection of clonally related sequences from cDNA of IgM+IgD+CD27+ B cells and naive B cells from donors 7 and 8 was performed with the following conditions: 30 µl reaction mixture containing 1.5 mM MgCl2, 250 µM dNTPs, 0.125 µM each primer (VH6FR1 or VH3-23 leader peptide primer and CDRIII-specific primer), primary denaturation step of 95°C for 4 min, followed by 35 cycles of 30 s at 95°C, 30 s at 62°C, 60 s at 72°C, and 5 min at 72°C. Resulting amplificates were cloned and multiple plasmids were sequenced. CDRIII-specific primers that amplified clonally related sequences in IgM+ B cells were in parallel used to amplify further clone members from IgG+ cDNA (see flowchart in Fig. 1 B). All distinct VH gene sequences are available at Genbank/EMBL/DDBJ under accession nos. FN562934FN562983, FN564030, and FN563492FN563831.

Mutation tree analysis.

Sequences with identical CDRIII were aligned by Clustal W (Megalign; DNAStar). The number of expected DNA polymerase errors per sequence was determined using the following formula: ~200 bp sequenced × 70 PCR cycles × polymerase error rate (8.3 × 10−6/bp/cycle [Roche]) = 0.1. Neglecting the low number of 1 expected polymerase induced error per 10 sequences, all nucleotides that did not match germline configuration of the respective VH gene were considered as mutations introduced by SHM. To create the IgV gene lineage trees, the sequences were manually positioned in genealogic order, rooted by the germline configuration and assuming that a high number of shared mutations in a sequence determines a late ancestor and vice versa. Each set of sequences was analyzed in parallel with the IgTree program (Barak et al., 2008; provided by R. Mehr, Bar-Ilan University, Ramat Gan Israel). Each genealogic tree was constructed to obtain a minimal amount of branching points and mutation events. In case the particular sequence of single mutation events could not be determined (e.g., possible back mutations were not outweighed by shared mutations or shared mutations could as well be interpreted as independent events), the solution in favor of a higher number of shared mutations is shown. Importantly, the basic structure of the tree was not affected.

Calculation of clonal sizes.

Assuming all members of a clone in the sorted cell aliquots were detected by the PCR-based strategy and counting repeatedly identified sequences as one, we calculated the potential clone size in the PB. For example, for the largest clone (Fig. 2 M, donor 7) for which we detected 37 members in the 3 × 106 sorted CD27+ B cells, in the total PB with ~1 × 109 CD19+ B cells (108 B cells in 500 ml PB, total blood volume of ~5 liter), of which 29% were CD27+, this clone would have in 5 liter of PB a size of ~3,600 B cells (37 × 109 x 0.29: 3 × 106). The sizes of the other clones were analogously determined.

Online supplemental material.

Fig. S1 shows the VH sequences obtained from the naive B cells of donors 7 and 8 using VH3-23– and CDRIII-specific primers for clones M, N, and O. Fig. S2 shows five selected sequences of each clone (A-P), aligned to the germline configuration of the corresponding V-, D-, and J-segments. Online supplemental material is available at http://www.jem.org/cgi/content/full/jem.20091087/DC1.

Acknowledgments

We thank Kerstin Heise for excellent technical assistance, Kai-Michael Toellner for sharing unpublished data and Ramit Mehr for providing the IgTree© software.

This work was supported by the Deutsche Forschungsgemeinschaft through Ku1315/4-1 and the Deutsche José Carreras Leukämie-Stiftung (R08/04).

The authors have no conflicting financial interests.

Footnotes

Abbreviations used:

BCR
B cell receptor
CDR
complementarity determining region
FR
framework region
GC
germinal center
MMC
major mutation cluster
PB
peripheral blood
SHM
somatic hypermutation
SNP
single-nucleotide polymorphism
TD
T cell dependent
TI
T cell independent

References

  • Agematsu K., Nagumo H., Yang F.C., Nakazawa T., Fukushima K., Ito S., Sugita K., Mori T., Kobata T., Morimoto C., Komiyama A. 1997. B cell subpopulations separated by CD27 and crucial collaboration of CD27+ B cells and helper T cells in immunoglobulin production. Eur. J. Immunol. 27:2073–2079 10.1002/eji.1830270835 [PubMed] [Cross Ref]
  • Allman D., Jain A., Dent A., Maile R.R., Selvaggi T., Kehry M.R., Staudt L.M. 1996. BCL-6 expression during B-cell activation. Blood. 87:5257–5268 [PubMed]
  • Bachl J., Carlson C., Gray-Schopfer V., Dessing M., Olsson C. 2001. Increased transcription levels induce higher mutation rates in a hypermutating cell line. J. Immunol. 166:5051–5057 [PubMed]
  • Barak M., Zuckerman N.S., Edelman H., Unger R., Mehr R. 2008. IgTree: creating immunoglobulin variable region gene lineage trees. J. Immunol. Methods. 338:67–74 10.1016/j.jim.2008.06.006 [PubMed] [Cross Ref]
  • Bernasconi N.L., Traggiai E., Lanzavecchia A. 2002. Maintenance of serological memory by polyclonal activation of human memory B cells. Science. 298:2199–2202 10.1126/science.1076071 [PubMed] [Cross Ref]
  • Bernasconi N.L., Onai N., Lanzavecchia A. 2003. A role for Toll-like receptors in acquired immunity: up-regulation of TLR9 by BCR triggering in naive B cells and constitutive expression in memory B cells. Blood. 101:4500–4504 10.1182/blood-2002-11-3569 [PubMed] [Cross Ref]
  • Blum K.S., Pabst R. 2007. Lymphocyte numbers and subsets in the human blood. Do they mirror the situation in all organs? Immunol. Lett. 108:45–51 10.1016/j.imlet.2006.10.009 [PubMed] [Cross Ref]
  • Brezinschek H.P., Brezinschek R.I., Lipsky P.E. 1995. Analysis of the heavy chain repertoire of human peripheral B cells using single-cell polymerase chain reaction. J. Immunol. 155:190–202 [PubMed]
  • Dunn-Walters D.K., Isaacson P.G., Spencer J. 1995. Analysis of mutations in immunoglobulin heavy chain variable region genes of microdissected marginal zone (MGZ) B cells suggests that the MGZ of human spleen is a reservoir of memory B cells. J. Exp. Med. 182:559–566 10.1084/jem.182.2.559 [PMC free article] [PubMed] [Cross Ref]
  • Fukita Y., Jacobs H., Rajewsky K. 1998. Somatic hypermutation in the heavy chain locus correlates with transcription. Immunity. 9:105–114 10.1016/S1074-7613(00)80592-0 [PubMed] [Cross Ref]
  • Good K.L., Tangye S.G. 2007. Decreased expression of Kruppel-like factors in memory B cells induces the rapid response typical of secondary antibody responses. Proc. Natl. Acad. Sci. USA. 104:13420–13425 10.1073/pnas.0703872104 [PubMed] [Cross Ref]
  • Good K.L., Bryant V.L., Tangye S.G. 2006. Kinetics of human B cell behavior and amplification of proliferative responses following stimulation with IL-21. J. Immunol. 177:5236–5247 [PubMed]
  • Harriman W., Völk H., Defranoux N., Wabl M. 1993. Immunoglobulin class switch recombination. Annu. Rev. Immunol. 11:361–384 10.1146/annurev.iy.11.040193.002045 [PubMed] [Cross Ref]
  • Hayakawa K., Ishii R., Yamasaki K., Kishimoto T., Hardy R.R. 1987. Isolation of high-affinity memory B cells: phycoerythrin as a probe for antigen-binding cells. Proc. Natl. Acad. Sci. USA. 84:1379–1383 10.1073/pnas.84.5.1379 [PubMed] [Cross Ref]
  • Klein U., Dalla-Favera R. 2008. Germinal centres: role in B-cell physiology and malignancy. Nat. Rev. Immunol. 8:22–33 10.1038/nri2217 [PubMed] [Cross Ref]
  • Klein U., Küppers R., Rajewsky K. 1997. Evidence for a large compartment of IgM-expressing memory B cells in humans. Blood. 89:1288–1298 [PubMed]
  • Klein U., Rajewsky K., Küppers R. 1998. Human immunoglobulin (Ig)M+IgD+ peripheral blood B cells expressing the CD27 cell surface antigen carry somatically mutated variable region genes: CD27 as a general marker for somatically mutated (memory) B cells. J. Exp. Med. 188:1679–1689 10.1084/jem.188.9.1679 [PMC free article] [PubMed] [Cross Ref]
  • Kruetzmann S., Rosado M.M., Weber H., Germing U., Tournilhac O., Peter H.H., Berner R., Peters A., Boehm T., Plebani A., et al. 2003. Human immunoglobulin M memory B cells controlling Streptococcus pneumoniae infections are generated in the spleen. J. Exp. Med. 197:939–945 10.1084/jem.20022020 [PMC free article] [PubMed] [Cross Ref]
  • Küppers R., Klein U., Hansmann M.L., Rajewsky K. 1999. Cellular origin of human B-cell lymphomas. N. Engl. J. Med. 341:1520–1529 10.1056/NEJM199911113412007 [PubMed] [Cross Ref]
  • Kuraoka M., Liao D., Yang K., Allgood S.D., Levesque M.C., Kelsoe G., Ueda Y. 2009. Activation-induced cytidine deaminase expression and activity in the absence of germinal centers: insights into hyper-IgM syndrome. J. Immunol. 183:3237–3248 10.4049/jimmunol.0901548 [PMC free article] [PubMed] [Cross Ref]
  • Liu Y.J., Oldfield S., MacLennan I.C. 1988. Memory B cells in T cell-dependent antibody responses colonize the splenic marginal zones. Eur. J. Immunol. 18:355–362 10.1002/eji.1830180306 [PubMed] [Cross Ref]
  • Longo N.S., Lugar P.L., Yavuz S., Zhang W., Krijger P.H., Russ D.E., Jima D.D., Dave S.S., Grammer A.C., Lipsky P.E. 2009. Analysis of somatic hypermutation in X-linked hyper-IgM syndrome shows specific deficiencies in mutational targeting. Blood. 113:3706–3715 10.1182/blood-2008-10-183632 [PubMed] [Cross Ref]
  • MacLennan I.C., Gulbranson-Judge A., Toellner K.M., Casamayor-Palleja M., Chan E., Sze D.M., Luther S.A., Orbea H.A. 1997. The changing preference of T and B cells for partners as T-dependent antibody responses develop. Immunol. Rev. 156:53–66 10.1111/j.1600-065X.1997.tb00958.x [PubMed] [Cross Ref]
  • Martinez-Gamboa L., Mei H., Loddenkemper C., Ballmer B., Hansen A., Lipsky P.E., Emmerich F., Radbruch A., Salama A., Dörner T. 2009. Role of the spleen in peripheral memory B-cell homeostasis in patients with autoimmune thrombocytopenia purpura. Clin. Immunol. 130:199–212 10.1016/j.clim.2008.09.009 [PubMed] [Cross Ref]
  • Pascual V., Liu Y.J., Magalski A., de Bouteiller O., Banchereau J., Capra J.D. 1994. Analysis of somatic mutation in five B cell subsets of human tonsil. J. Exp. Med. 180:329–339 10.1084/jem.180.1.329 [PMC free article] [PubMed] [Cross Ref]
  • Pasqualucci L., Migliazza A., Fracchiolla N., William C., Neri A., Baldini L., Chaganti R.S., Klein U., Küppers R., Rajewsky K., Dalla-Favera R. 1998. BCL-6 mutations in normal germinal center B cells: evidence of somatic hypermutation acting outside Ig loci. Proc. Natl. Acad. Sci. USA. 95:11816–11821 10.1073/pnas.95.20.11816 [PubMed] [Cross Ref]
  • Pasqualucci L., Migliazza A., Basso K., Houldsworth J., Chaganti R.S., Dalla-Favera R. 2003. Mutations of the BCL6 proto-oncogene disrupt its negative autoregulation in diffuse large B-cell lymphoma. Blood. 101:2914–2923 10.1182/blood-2002-11-3387 [PubMed] [Cross Ref]
  • Peng H.Z., Du M.Q., Koulis A., Aiello A., Dogan A., Pan L.X., Isaacson P.G. 1999. Nonimmunoglobulin gene hypermutation in germinal center B cells. Blood. 93:2167–2172 [PubMed]
  • Rajewsky K. 1996. Clonal selection and learning in the antibody system. Nature. 381:751–758 10.1038/381751a0 [PubMed] [Cross Ref]
  • Reynaud C.A., Garcia C., Hein W.R., Weill J.C. 1995. Hypermutation generating the sheep immunoglobulin repertoire is an antigen-independent process. Cell. 80:115–125 10.1016/0092-8674(95)90456-5 [PubMed] [Cross Ref]
  • Richards S.J., Morgan G.J., Hillmen P. 2000. Immunophenotypic analysis of B cells in PNH: insights into the generation of circulating naive and memory B cells. Blood. 96:3522–3528 [PubMed]
  • Rogozin I.B., Kolchanov N.A. 1992. Somatic hypermutagenesis in immunoglobulin genes. II. Influence of neighbouring base sequences on mutagenesis. Biochim. Biophys. Acta. 1171:11–18 [PubMed]
  • Scheeren F.A., Nagasawa M., Weijer K., Cupedo T., Kirberg J., Legrand N., Spits H. 2008. T cell-independent development and induction of somatic hypermutation in human IgM+ IgD+ CD27+ B cells. J. Exp. Med. 205:2033–2042 10.1084/jem.20070447 [PMC free article] [PubMed] [Cross Ref]
  • Shackelford P.G., Nelson S.J., Palma A.T., Nahm M.H. 1988. Human antibodies to group A streptococcal carbohydrate. Ontogeny, subclass restriction, and clonal diversity. J. Immunol. 140:3200–3205 [PubMed]
  • Shan H., Shlomchik M., Weigert M. 1990. Heavy-chain class switch does not terminate somatic mutation. J. Exp. Med. 172:531–536 10.1084/jem.172.2.531 [PMC free article] [PubMed] [Cross Ref]
  • Shen H.M., Peters A., Baron B., Zhu X., Storb U. 1998. Mutation of BCL-6 gene in normal B cells by the process of somatic hypermutation of Ig genes. Science. 280:1750–1752 10.1126/science.280.5370.1750 [PubMed] [Cross Ref]
  • Shi Y., Agematsu K., Ochs H.D., Sugane K. 2003. Functional analysis of human memory B-cell subpopulations: IgD+CD27+ B cells are crucial in secondary immune response by producing high affinity IgM. Clin. Immunol. 108:128–137 10.1016/S1521-6616(03)00092-5 [PubMed] [Cross Ref]
  • Song H., Cerny J. 2003. Functional heterogeneity of marginal zone B cells revealed by their ability to generate both early antibody-forming cells and germinal centers with hypermutation and memory in response to a T-dependent antigen. J. Exp. Med. 198:1923–1935 10.1084/jem.20031498 [PMC free article] [PubMed] [Cross Ref]
  • Tangye S.G., Liu Y.J., Aversa G., Phillips J.H., de Vries J.E. 1998. Identification of functional human splenic memory B cells by expression of CD148 and CD27. J. Exp. Med. 188:1691–1703 10.1084/jem.188.9.1691 [PMC free article] [PubMed] [Cross Ref]
  • Tangye S.G., Avery D.T., Deenick E.K., Hodgkin P.D. 2003a. Intrinsic differences in the proliferation of naive and memory human B cells as a mechanism for enhanced secondary immune responses. J. Immunol. 170:686–694 [PubMed]
  • Tangye S.G., Avery D.T., Hodgkin P.D. 2003b. A division-linked mechanism for the rapid generation of Ig-secreting cells from human memory B cells. J. Immunol. 170:261–269 [PubMed]
  • Wasserstrom H., Bussel J., Lim L.C., Cunningham-Rundles C. 2008. Memory B cells and pneumococcal antibody after splenectomy. J. Immunol. 181:3684–3689 [PMC free article] [PubMed]
  • Weinstein P.D., Anderson A.O., Mage R.G. 1994. Rabbit IgH sequences in appendix germinal centers: VH diversification by gene conversion-like and hypermutation mechanisms. Immunity. 1:647–659 10.1016/1074-7613(94)90036-1 [PubMed] [Cross Ref]
  • Weiss U., Rajewsky K. 1990. The repertoire of somatic antibody mutants accumulating in the memory compartment after primary immunization is restricted through affinity maturation and mirrors that expressed in the secondary response. J. Exp. Med. 172:1681–1689 10.1084/jem.172.6.1681 [PMC free article] [PubMed] [Cross Ref]
  • Weller S., Faili A., Garcia C., Braun M.C., Le Deist F F., de Saint Basile G G., Hermine O., Fischer A., Reynaud C.A., Weill J.C. 2001. CD40-CD40L independent Ig gene hypermutation suggests a second B cell diversification pathway in humans. Proc. Natl. Acad. Sci. USA. 98:1166–1170 10.1073/pnas.98.3.1166 [PubMed] [Cross Ref]
  • Weller S., Braun M.C., Tan B.K., Rosenwald A., Cordier C., Conley M.E., Plebani A., Kumararatne D.S., Bonnet D., Tournilhac O., et al. 2004. Human blood IgM “memory” B cells are circulating splenic marginal zone B cells harboring a prediversified immunoglobulin repertoire. Blood. 104:3647–3654 10.1182/blood-2004-01-0346 [PMC free article] [PubMed] [Cross Ref]
  • Yang S.Y., Fugmann S.D., Schatz D.G. 2006. Control of gene conversion and somatic hypermutation by immunoglobulin promoter and enhancer sequences. J. Exp. Med. 203:2919–2928 10.1084/jem.20061835 [PMC free article] [PubMed] [Cross Ref]
  • Yavuz A.S., Monson N.L., Yavuz S., Grammer A.C., Longo N., Girschick H.J., Lipsky P.E. 2002. Different patterns of bcl-6 and p53 gene mutations in tonsillar B cells indicate separate mutational mechanisms. Mol. Immunol. 39:485–493 10.1016/S0161-5890(02)00117-7 [PubMed] [Cross Ref]
  • Ye B.H., Lista F., Lo Coco F., Knowles D.M., Offit K., Chaganti R.S., Dalla-Favera R. 1993. Alterations of a zinc finger-encoding gene, BCL-6, in diffuse large-cell lymphoma. Science. 262:747–750 10.1126/science.8235596 [PubMed] [Cross Ref]
  • Zandvoort A., Lodewijk M.E., de Boer N.K., Dammers P.M., Kroese F.G., Timens W. 2001. CD27 expression in the human splenic marginal zone: the infant marginal zone is populated by naive B cells. Tissue Antigens. 58:234–242 10.1034/j.1399-0039.2001.580403.x [PubMed] [Cross Ref]

Articles from The Journal of Experimental Medicine are provided here courtesy of The Rockefeller University Press